Permeability issues in nasal drug delivery
- PMID: 12546871
- DOI: 10.1016/s1359-6446(02)02452-2
Permeability issues in nasal drug delivery
Abstract
The nasal route is one of the most permeable and highly vascularized site for drug administration ensuring rapid absorption and onset of therapeutic action. It has been potentially explored as an alternative route for drugs with poor bioavailability and for the delivery of biosensitive and high molecular weight (MW) compounds such as proteins, peptides, steroids, vaccines, and so on. This review discusses the major factors affecting the permeability of drugs or biomolecules through the nasal mucosa, including biological, formulation and device-related factors. This information could potentially help to achieve desired plasma concentrations of drugs without compromising or altering the normal physiology of the nasal cavity.
Similar articles
-
Nasal delivery of high molecular weight drugs.Molecules. 2009 Sep 23;14(9):3754-79. doi: 10.3390/molecules14093754. Molecules. 2009. PMID: 19783956 Free PMC article. Review.
-
Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.Eur J Pharm Biopharm. 2014 Sep;88(1):8-27. doi: 10.1016/j.ejpb.2014.03.004. Epub 2014 Mar 28. Eur J Pharm Biopharm. 2014. PMID: 24681294 Review.
-
Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats.Eur J Pharm Biopharm. 2020 Apr;149:145-153. doi: 10.1016/j.ejpb.2020.02.004. Epub 2020 Feb 11. Eur J Pharm Biopharm. 2020. PMID: 32057906
-
The nasal delivery of systemic drugs.Int J Clin Pract. 1997 Jul-Aug;51(5):308-11. Int J Clin Pract. 1997. PMID: 9489091 Review.
-
Nasal route for vaccine and drug delivery: Features and current opportunities.Int J Pharm. 2019 Dec 15;572:118813. doi: 10.1016/j.ijpharm.2019.118813. Epub 2019 Oct 31. Int J Pharm. 2019. PMID: 31678521 Review.
Cited by
-
Just how prevalent are peptide therapeutic products? A critical review.Int J Pharm. 2020 Sep 25;587:119491. doi: 10.1016/j.ijpharm.2020.119491. Epub 2020 Jul 3. Int J Pharm. 2020. PMID: 32622810 Free PMC article. Review.
-
Poloxamer-chitosan-based Naringenin nanoformulation used in brain targeting for the treatment of cerebral ischemia.Saudi J Biol Sci. 2020 Jan;27(1):500-517. doi: 10.1016/j.sjbs.2019.11.008. Epub 2019 Nov 22. Saudi J Biol Sci. 2020. PMID: 31889876 Free PMC article.
-
Use of Biopolymers in Mucosally-Administered Vaccinations for Respiratory Disease.Materials (Basel). 2019 Jul 31;12(15):2445. doi: 10.3390/ma12152445. Materials (Basel). 2019. PMID: 31370286 Free PMC article. Review.
-
Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: Phase I healthy volunteer study.Addiction. 2018 Mar;113(3):484-493. doi: 10.1111/add.14033. Epub 2017 Nov 16. Addiction. 2018. PMID: 29143400 Free PMC article. Clinical Trial.
-
Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders.Acta Pharm Sin B. 2023 May;13(5):1866-1886. doi: 10.1016/j.apsb.2022.07.003. Epub 2022 Jul 9. Acta Pharm Sin B. 2023. PMID: 37250152 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical